Impact of Aaron Siri's actions on US vaccine mandate policies by end of 2025
Increased mandates • 25%
Decreased mandates • 25%
No change • 25%
Unclear impact • 25%
Legislative changes or official policy announcements from federal or state health departments
RFK Jr.'s Lawyer Seeks Revocation of Polio Vaccine Approval, Citing Safety Concerns
Dec 13, 2024, 03:45 PM
Aaron Siri, a lawyer assisting Robert F. Kennedy Jr. in selecting federal health officials for the incoming Trump administration, has petitioned the U.S. Food and Drug Administration (FDA) to revoke its approval of the polio vaccine. This action is part of a wider campaign against vaccines, where Siri has also challenged and in some cases quashed Covid vaccine mandates, sued federal agencies for vaccine-related records, and subjected vaccine scientists to extensive depositions. His efforts are largely on behalf of the Informed Consent Action Network, a nonprofit advocating for medical freedom. Despite Kennedy's statements that he does not intend to remove access to vaccines, his collaboration with Siri suggests a potential sharp scrutiny of vaccine policy. Siri has also filed to pause distribution of 13 other vaccines, including the hepatitis B vaccine, citing concerns over the safety of aluminum in vaccines and the lack of double-blind randomized controlled trials (RCTs) for these vaccines. This raises concerns among public health experts about the implications for vaccine-preventable diseases.
View original story
No decision • 25%
All approved • 25%
All revoked • 25%
Some revoked • 25%
Weakened mandates • 25%
Other outcomes • 25%
No change • 25%
Strengthened mandates • 25%
Neutral stance • 25%
Pro-vaccine mandates • 25%
Anti-vaccine mandates • 25%
Other • 25%
Mixed responses • 25%
No significant change • 25%
Decreased trust • 25%
Increased trust • 25%
Aaron Siri • 25%
Robert F. Kennedy Jr. • 25%
Other • 25%
Donald Trump • 25%
Other changes • 25%
Looser vaccine mandates • 25%
No change • 25%
Stricter vaccine mandates • 25%
Rejection of changes • 25%
Approval of changes • 25%
Calls for further review • 25%
No official stance • 25%
Unclear • 25%
More restrictive • 25%
Less restrictive • 25%
No change • 25%
No significant changes • 25%
Increased oversight • 25%
Reduced oversight • 25%
Other changes • 25%
Decrease by more than 5% • 25%
Fluctuate without clear trend • 25%
Increase by more than 5% • 25%
No significant change • 25%
No change • 25%
Other • 25%
Decreased distribution • 25%
Increased distribution • 25%
4-7 Vaccines • 25%
0-3 Vaccines • 25%
8-11 Vaccines • 25%
12-14 Vaccines • 25%
No influence • 25%
Unknown influence • 25%
Major influence • 25%
Minor influence • 25%